The content on this site is intended for healthcare professionals only
Dr Cohen presents analysis at the San Antonio Breast Cancer Symposium 2016 of primary and metastatic breast cancer biopsies, with samples matched where available, which underwent whole exome sequencing and transcriptome sequencing to give a clearer view of tumour evolution.
He highlights notable acquired mutations in ER positive MBC, which may inform treatment choice for patients and target choice for future research.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
SABCS 2025: Latest developments in multigene testing in early breast cancer
AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab
Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Best practice in HRRm testing in patients with metastatic prostate cancer
Multiple myeloma in a resource constrained setting
SABCS 2023: Latest breast cancer diagnostics guidelines
Choosing Wisely in pathology
